An experimental gene therapy developed at Seattle’s Fred Hutchinson Cancer Center “eliminated 90% of facial infection and 97% of genital infection in lab mice who were infected with herpes simplex 1,” U.S. News reported on May 15, 2024 (read story here to find out how it works). Watch the video below.